Leading the Way in Neonatal Therapies

Feb 26, 2019

Buffalo Business First speaks to ONY Biotech about the company’s continued strides toward creating innovative therapies to improve outcomes for premature babies and their families. With a clinical trial for an aerosolized surfactant therapy recently completed and other product developments underway, ONY Biotech is poised to change the landscape of neonatal respiratory therapy as it’s currently known with the potential for minimally invasive alternatives.

See full article:

ONY Biotech’s Promising Future